Skip to main content

Transfusion burden among older US patients with relapsed FLT3-mutated Acute Myeloid Leukemia treated with gilteritinib: A Medicare claims-based cohort study

Conferences
LeBlanc, T; Block, A; Young, C; Gurumoorthy, G; Kardel, P; Pednekar, P
Published in: Blood
November 3, 2025

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 3, 2025

Volume

146

Issue

Supplement 1

Start / End Page

1664 / 1664

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
LeBlanc, T., Block, A., Young, C., Gurumoorthy, G., Kardel, P., & Pednekar, P. (2025). Transfusion burden among older US patients with relapsed FLT3-mutated Acute Myeloid Leukemia treated with gilteritinib: A Medicare claims-based cohort study. In Blood (Vol. 146, pp. 1664–1664). American Society of Hematology. https://doi.org/10.1182/blood-2025-1664
LeBlanc, Thomas, Alana Block, Christopher Young, Giridharan Gurumoorthy, Peter Kardel, and Priti Pednekar. “Transfusion burden among older US patients with relapsed FLT3-mutated Acute Myeloid Leukemia treated with gilteritinib: A Medicare claims-based cohort study.” In Blood, 146:1664–1664. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-1664.
LeBlanc T, Block A, Young C, Gurumoorthy G, Kardel P, Pednekar P. Transfusion burden among older US patients with relapsed FLT3-mutated Acute Myeloid Leukemia treated with gilteritinib: A Medicare claims-based cohort study. In: Blood. American Society of Hematology; 2025. p. 1664–1664.
LeBlanc, Thomas, et al. “Transfusion burden among older US patients with relapsed FLT3-mutated Acute Myeloid Leukemia treated with gilteritinib: A Medicare claims-based cohort study.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 1664–1664. Crossref, doi:10.1182/blood-2025-1664.
LeBlanc T, Block A, Young C, Gurumoorthy G, Kardel P, Pednekar P. Transfusion burden among older US patients with relapsed FLT3-mutated Acute Myeloid Leukemia treated with gilteritinib: A Medicare claims-based cohort study. Blood. American Society of Hematology; 2025. p. 1664–1664.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 3, 2025

Volume

146

Issue

Supplement 1

Start / End Page

1664 / 1664

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology